Updating results

2029 results

Sort: Relevance | Date

The percentage of patients with a new diagnosis of hypertension in the preceding 12 months who have been screened for hazardous drinking using the FAST or AUDIT-C tool in the 3 months before or after the date of entry on the hypertension register

The percentage of patients with a new diagnosis of hypertension in the preceding 12 months who have been screened for hazardous drinking using the...

General practice indicator suitable for use in the QOF Published October 2019

The percentage of patients with a new diagnosis of hypertension in the preceding 12 months with a FAST score of ≥3 or AUDIT-C score of ≥5 who have received brief intervention to help them reduce their alcohol related risk within 3 months of the score being recorded

The percentage of patients with a new diagnosis of hypertension in the preceding 12 months with a FAST score of ≥3 or AUDIT-C score of ≥5 who have...

General practice indicator suitable for use in the QOF Published October 2019

The percentage of patients with a new diagnosis of hypertension in the preceding 1st April to 31st March who have a record of a 12 lead ECG performed in the three months before or after the date of entry to the hypertension register

The percentage of patients with a new diagnosis of hypertension in the preceding 1st April to 31st March who have a record of a 12 lead ECG performed...

General practice indicator suitable for use in the QOF Published August 2019

The percentage of patients with a new diagnosis of hypertension in the preceding 1st April to 31st March who have a record of a test for haematuria in the three months before or after the date of entry to the hypertension register.

The percentage of patients with a new diagnosis of hypertension in the preceding 1st April to 31st March who have a record of a test for haematuria in

General practice indicator suitable for use in the QOF Published August 2019

The percentage of patients with a new diagnosis of hypertension in the preceding 1st April to 31st March who have a record of urinary albumin: creatinine ratio test in the three months before or after the date of entry to the hypertension register

The percentage of patients with a new diagnosis of hypertension in the preceding 1st April to 31st March who have a record of urinary albumin:...

General practice indicator suitable for use in the QOF Published August 2019

The percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD or asthma, whose notes record smoking status in the preceding 12 months

The percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD or...

General practice indicator suitable for use in the QOF Published August 2019

The percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma who are recorded as current smokers who have a record of an offer of support and treatment within the preceding 12 months

The percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma

General practice indicator suitable for use in the QOF Published August 2019

The percentage of patients with asthma aged 14 or over and who have not attained the age of 20, on the register, in whom there is a record of smoking status in the preceding 12 months. (Inherited)

The percentage of patients with asthma aged 14 or over and who have not attained the age of 20, on the register, in whom there is a record of smoking...

General practice indicator suitable for use in the QOF Published June 2016

Admissions rates due to myocardial infarction in people with diabetes

Admissions rates due to myocardial infarction in people with diabetes Subject(s): Diabetes Date of publication: 01

Clinical Commissioning Group indicator Published July 2016

Admissions rates for renal replacement therapy in people with diabetes

Admissions rates for renal replacement therapy in people with diabetes Subject(s): Diabetes Date of publication:

Clinical Commissioning Group indicator Published July 2016

Breast cancer mortality rates

Breast cancer mortality rates Subject(s): Cancer NICE identity code: CCG04

Clinical Commissioning Group indicator Published June 2016

The proportion of invasive cases of cancer diagnosed via an emergency route

The proportion of invasive cases of cancer diagnosed via an emergency route Subject(s): Cancer

Clinical Commissioning Group indicator Published June 2016

The proportion of new cases of cancer with a stage of diagnosis recorded

The proportion of new cases of cancer with a stage of diagnosis recorded Subject(s): Cancer Date of publication:

Clinical Commissioning Group indicator Published June 2016

The proportion of people with cancer who have the cancer detected at stage 1 or 2

The proportion of people with cancer who have the cancer detected at stage 1 or 2 Subject(s): Cancer

Clinical Commissioning Group indicator Published June 2016

The proportion of people with COPD and MRC dyspnoea scale 3 and above referred to a pulmonary rehabilitation programme

The proportion of people with COPD and MRC dyspnoea scale 3 and above referred to a pulmonary rehabilitation programme Subject(s):

Clinical Commissioning Group indicator Published June 2016

The proportion of people with coronary heart disease referred for cardiac rehabilitation

The proportion of people with coronary heart disease referred for cardiac rehabilitation Subject(s): Heart failure

Clinical Commissioning Group indicator Published June 2016

Proportion of people with dementia prescribed anti-psychotic medication

Proportion of people with dementia prescribed anti-psychotic medication Subject(s): Dementia

Clinical Commissioning Group indicator Published June 2016

The proportion of adults with a diagnosis of diabetes who have a recording of MI, stroke and/or end stage kidney disease

The proportion of adults with a diagnosis of diabetes who have a recording of MI, stroke and/or end stage kidney disease Subject(s):

Clinical Commissioning Group indicator Published June 2016

The proportion of adults with diabetes who have received all nine basic care processes.

The proportion of adults with diabetes who have received all nine basic care processes. Subject(s): Diabetes

Clinical Commissioning Group indicator Published June 2016

The proportion of adults with diabetes referred to a structured education programme within 12 months of diagnosis

The proportion of adults with diabetes referred to a structured education programme within 12 months of diagnosis Subject(s): Diabetes

Clinical Commissioning Group indicator Published June 2016

The proportion of adults with diabetes who have an emergency admission for diabetic ketoacidosis

The proportion of adults with diabetes who have an emergency admission for diabetic ketoacidosis Subject(s): Diabetes

Clinical Commissioning Group indicator Published June 2016

Proportion of adults with diabetes with a HES recording of National Diabetes Audit complications

Proportion of adults with diabetes with a HES recording of National Diabetes Audit complications Subject(s): Diabetes

Clinical Commissioning Group indicator Published June 2016

Admission rates due to diabetic ketoacidosis in people with diabetes

Admission rates due to diabetic ketoacidosis in people with diabetes Subject(s): Diabetes Date of publication: 01

Clinical Commissioning Group indicator Published July 2016

All cause mortality - 12 months following admission to hospital for heart failure

All cause mortality - 12 months following admission to hospital for heart failure Subject(s): Heart failure

Clinical Commissioning Group indicator Published June 2016

Admission rates due to heart failure in people with diabetes

Admission rates due to heart failure in people with diabetes Subject(s): Diabetes Date of publication: 01 August

Clinical Commissioning Group indicator Published July 2016

Admission rates due to lower limb amputations in people with diabetes

Admission rates due to lower limb amputations in people with diabetes Subject(s): Diabetes Date of publication: 01

Clinical Commissioning Group indicator Published July 2016

The proportion of people with hip fracture, who receive a multifactorial risk assessment of future falls risk

The proportion of people with hip fracture, who receive a multifactorial risk assessment of future falls risk Subject(s): Hip fracture

Clinical Commissioning Group indicator Published June 2016

Admission rates due to stroke in people with diabetes

Admission rates due to stroke in people with diabetes Subject(s): Diabetes Date of publication: 01 August 2016

Clinical Commissioning Group indicator Published July 2016

The percentage of patients with coronary heart disease who have had influenza immunisation in the preceding 1 August to 31 March (Inherited)

The percentage of patients with coronary heart disease who have had influenza immunisation in the preceding 1 August to 31 March (Inherited)

General practice indicator suitable for use in the QOF Published March 2017

The Juxta CURES adjustable compression system for treating venous leg ulcers (MIB25)

Advice on the use of the Juxta CURES adjustable compression system for treating venous leg ulcers to aid local decision-making

Medtech innovation briefing Published March 2015

The Epidrum for aiding access to the epidural space (MIB23)

Advice on the use of the Epidrum for aiding access to the epidural space to aid local decision-making

Medtech innovation briefing Published March 2015

Shiley Endotracheal Tube with TaperGuard Cuff for intensive care patients at risk of ventilator‑associated pneumonia (MIB22)

Advice on the use of Shiley Endotracheal Tube with TaperGuard Cuff for patients at risk of ventilator-associated pneumonia to aid local decision-making

Medtech innovation briefing Published March 2015

The SpyGlass direct visualisation system for diagnostic and therapeutic procedures during endoscopy of the biliary system (MIB21)

Advice on the use of The SpyGlass direct visualisation system for diagnostic and therapeutic procedures during endoscopy of the biliary system..

Medtech innovation briefing Published February 2015

PulmoVista 500 for monitoring ventilation in critical care (MIB203)

Advice on the use of PulmoVista 500 for monitoring ventilation in critical care to aid local decision making

Medtech innovation briefing Published December 2019

LQD Spray for treating acute and chronic wounds (MIB202)

Advice on the use of LQD Spray (spray-on dressing containing modified biopolymer chitosan FH02) for treating acute/chronic wounds to aid local decision making

Medtech innovation briefing Published December 2019

eXroid for internal haemorrhoids (MIB201)

Advice on the use of eXroid, using direct current electrotherapy to blood vessels of internal haemorrhoid to shrink haemorrhoids, to aid local decision making

Medtech innovation briefing Published December 2019

PIUR tUS for abdominal aortic aneurysm surveillance and endovascular aneurysm repair endoleak detection (MIB200)

Advice on the use of PIUR tUS for abdominal aortic aneurysm surveillance and endovascular aneurysm repair endoleak detection to aid local decision making

Medtech innovation briefing Published December 2019

The PressureWire fractional flow reserve measurement system for coronary artery disease (MIB2)

Advice on the use of the PressureWire fractional flow reserve measurement system for coronary artery disease to aid local decision-making

Medtech innovation briefing Published February 2014

ATEC system for vacuum-assisted breast biopsy (MIB43)

Advice on the use of the ATEC system for vacuum-assisted breast biopsy to aid local decision-making

Medtech innovation briefing Published November 2015

PROPATEN heparin-bonded vascular graft for peripheral arterial disease (MIB42)

Advice on the use of the PROPATEN heparin-bonded vascular graft for treating peripheral arterial disease to aid local decision-making

Medtech innovation briefing Published October 2015

Active B12 assay for diagnosing vitamin B12 deficiency (MIB40)

Advice on the use of the Active B12 assay for diagnosing vitamin B12 deficiency to aid local decision-making

Medtech innovation briefing Published September 2015

The RhinoChill intranasal cooling system for reducing temperature after cardiac arrest (MIB4)

Advice on the use of the RhinoChill intranasal cooling system for reducing temperature after cardiac arrest to aid local decision-making

Medtech innovation briefing Published February 2014

ERBE flexible cryoprobes for bronchoscopic diagnosis and treatment (MIB39)

Advice on the use of ERBE flexible cryoprobes for bronchoscopic diagnosis and treatment to aid local decision-making

Medtech innovation briefing Published September 2015

i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department (MIB38)

Advice on the use of the i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department to aid local decision-making

Medtech innovation briefing Published September 2015

Thermogard XP for therapeutic hypothermia after cardiac arrest (MIB37)

Advice on the use of the Thermogard XP system for treating therapeutic hypothermia after cardiac arrest to aid local decision-making

Medtech innovation briefing Published September 2015

Visensia for early detection of deteriorating vital signs in adults in hospital (MIB36)

Advice on the use of the Visensia for early detection of deteriorating vital signs in adults in hospital to aid local decision-making

Medtech innovation briefing Published August 2015